Who are Pfizer's key investors?

Key investors in Pfizer include Starboard Value and HHS Administration for Strategic Preparedness and Response.

How many employees does Pfizer have?

As of Sat, 25 Apr 2026, Pfizer has approximately 10,001+ employees employees.

How much website traffic does Pfizer receive?

Pfizer receives about 1.9M monthly website visits in the latest Datakart source snapshot. This helps benchmark market attention, demand generation, and digital reach.

Is Pfizer currently hiring?

Pfizer has 709 open roles in the latest source snapshot. Open job volume can indicate team expansion, budget movement, and active buying needs by department.

What technologies does Pfizer use?

Pfizer's detected technology footprint includes Sqlite, Python, Ecl, Azure Data Lake, Postman, Unix Shell Scripts. The full profile lists additional verified technologies when available.

Company profile

Pharmaceutical Manufacturing

Pfizer - Company Intelligence Profile

Industry: Pharmaceutical Manufacturing | Founded: not publicly disclosed | HQ: New York, United States

We’re celebrating over 175 years of daring scientific innovation—and we’re not done yet. Let’s outdo yesterday. Protect your health at PfizerForAll.com

Datakart tracks firmographic, hiring, traffic, technology, funding, review, and leadership signals for Pfizer to help teams evaluate the account with useful business context.

Public company

Pfizer

pfizer.com

Employees

103.3K

Monthly visits

1.9M

Open roles

709

Search volume

40.5K

View intelligence Start free trial

Company Snapshot

We’re celebrating over 175 years of daring scientific innovation—and we’re not done yet. Let’s outdo yesterday. Protect your health at PfizerForAll.com

For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines

N/A

Founded

103.3K

Employee count

1.9M

Monthly website visits

709

Open roles

Company Snapshot Details

Legal name: Pfizer Inc.

Headquarters: New York, New York, United States

Industry: Pharmaceutical Manufacturing

Sub-sector: Pharmaceutical Manufacturing

Website: https://www.pfizer.com

YoY headcount growth: not publicly disclosed

Company stage: Public Company

Last updated: Sat, 25 Apr 2026

Company intelligence

Business signals that help qualify Pfizer

This profile combines firmographic, traffic, hiring, employee, review, compensation, technology, funding, leadership, and product availability signals so visitors can answer practical business questions without hunting across multiple data sources.

Source snapshot

Last refreshed 2026-04-25 | 41K search volume | Domain pfizer.com

Annual revenue

$62.6B

Reported annual revenue from the source dataset when available.

Quarterly revenue

$16.7B

Standalone quarterly revenue field from the source dataset.

Monthly visits

1.9M

Latest monthly visits value available from the source dataset.

Global web rank

#32,098

Lower rank values indicate stronger web visibility in the source dataset.

Employees

103.3K

Latest employees value available from the source dataset.

-83 monthly (-10.5%)

Hiring demand

709

Open roles reveal which teams may be expanding and where vendor demand can emerge. For Pfizer, this signal is based on the latest available source snapshot.

+798 monthly (+0.8%)

Headcount momentum

103.3K

Recent employee count movement helps qualify growth, contraction, and operational scale. For Pfizer, this signal is based on the latest available source snapshot.

+50K monthly (+0.7%)

Audience growth

LinkedIn follower movement is a useful proxy for employer brand, market attention, and hiring reach. For Pfizer, this signal is based on the latest available source snapshot.

+26.9K monthly (+1.4%)

Web demand

1.9M

Website traffic movement helps benchmark customer interest and go-to-market momentum. For Pfizer, this signal is based on the latest available source snapshot.

Identity atlas

Pfizer identity, aliases, ownership, and taxonomy

This section makes the entity easier to verify: canonical domains, alternate names, descriptions, ownership flags, parent or acquirer context, industry codes, and source-level social reach are grouped together.

Company descriptions

All available company description fields from the source dataset.

Company descriptiondescription

We’re celebrating over 175 years of daring scientific innovation—and we’re not done yet. Let’s outdo yesterday. Protect your health at PfizerForAll.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines

Enriched descriptionDescription Enriched

Pfizer is one of the world's premier biopharmaceutical companies that focuses on breakthroughs that change patients' lives.

Metadata descriptionDescription Metadata Raw

Discover the commonalities and differences between biologics vs. biosimilars — especially when it comes to cost.

LinkedIn followers

Latest linkedin followers value available from the source dataset.

Owler followers

33.6K

Latest owler followers value available from the source dataset.

Technologies detected

1.2K

Latest technologies detected value available from the source dataset.

Ownership and corporate structure

Ownership status, parent company, acquisition status, and public/B2B flags.

Operating status

Active

Independent Company

Company type

Public Company

type

Ownership status

Public

Ownership Status

Public company

Yes

Is Public

Aliases and domain variants

Company name aliases, website aliases, and canonical domain signals.

Company alias

pfizer

Company Name Alias

Company alias

pfizer, inc.

Company Name Alias

Company alias

pfizer inc.

Company Name Alias

Website alias

https://www.pfizer.com

Website Alias

Website alias

https://www.pfizer.com/?source=linkedin

Website Alias

Website alias

https://www.pfizer.com/

Website Alias

Canonical website

https://www.pfizer.com

website

Website domain

pfizer.com

Website Domain

Unique website

Yes

Unique Website

Unique domain

Yes

Unique Domain

Expired domain

Expired Domain

LinkedIn shorthand

pfizer

Canonical LinkedIn Shorthand Name

Source ID

1185

Source ID

UUID

537SEW4CQE80BWJZXW5MVCN99D

uuid

Industry classification codes

SIC, NAICS, industry, and keyword classification signals.

Industry

Pharmaceutical Manufacturing

industry

Categories and keywords

['biopharmaceutical', 'breakthroughs', 'patients', 'premier', 'lives', 'health', 'biotech', 'clinical-research', 'drug-development', 'pharma', 'biotechnology', 'health care', 'medical', 'pharmaceutical', 'precision medicine']

Categories And Keywords

Social follower counts

Follower counts available across LinkedIn, Twitter, and Owler.

LinkedIn followers

Followers Count LinkedIn

Owler followers

33.6K

Followers Count Owler

Company locations

Known company locations and office addresses.

Primary location

New York; New York, New York 10017, US

Office location

31 Tuas South Ave 6; Singapore, Singapore 637578, SG

Office location

500 Arcola Rd; Collegeville, PA 19426, US

Office location

1040 Swabia Ct; Durham, NC 27703, US

Office location

Via Isonzo, 71; Latina, Laz. 04100, IT

Office location

No. 177, Sec 2, Zhong Zheng E. Rd.; New Taipei City, New Taipei City 251, TW

Office location

85 Bute Ln; Sandton, Gauteng 2196, ZA

Office location

1200 Parkdale Rd; Rochester, MI 48307, US

Social profiles

Official and source-linked social profiles.

Website

https://www.pfizer.com

https://www.linkedin.com/company/pfizer

Crunchbase

https://www.crunchbase.com/organization/pfizer

Facebook

https://www.facebook.com/pfizercareers

Twitter / X

https://www.twitter.com/pfizer

Instagram

https://www.instagram.com/pfizercareers

YouTube

https://www.youtube.com/pfizer

Company contact points

Public company-level contact points available in the source dataset.

Phone

1-800-879-3477

Financial intelligence

Pfizer revenue, funding, IPO, and acquisition history

Financial signals are grouped as an analyst-style view: revenue sources, income statement rows, funding rounds, acquisition activity, IPO fields, stock listing context, and ownership structure.

Annual revenue

$62.6B

Reported annual revenue from the source dataset when available.

Quarterly revenue

$16.7B

Standalone quarterly revenue field from the source dataset.

Total disclosed funding

$39.2B

Sum of disclosed funding round amounts available in the source dataset.

Funding rounds

Number of funding rounds captured in the source dataset.

Acquisitions captured

116

Number of acquisition records captured across the available source columns.

Revenue signals

Annual, quarterly, and range-based revenue signals available in the source dataset.

Source 5

$62.6B

Annual revenue

Source 1$62.6B

Standalone quarterly revenue$16.7B

IPO and stock listing

IPO date, share price, exchange tickers, and public market identifiers.

IPO date

1978-01-13

IPO Date

Stock tickerPFE

Latest closing price$28.46

Ownership and corporate structure

Ownership status, parent company, acquisition status, and public/B2B flags.

Operating status

Active

Independent Company

Company type

Public Company

type

Ownership status

Public

Ownership Status

Public company

Yes

Is Public

Income statement rows

Income statement rows with revenue and profitability metrics where available.

FY, 2025

Fiscal Year

Primary value

Revenue: $62.6B

Additional metrics

Gross profit: $46.5B; Net income: $7.8B; Operating expense: $24.2B; Gross margin: 74.3%; EPS: 1.36

Q3, 2025

Primary value

Revenue: $16.7B

Additional metrics

Gross profit: $12.5B; Net income: $3.6B; Operating expense: $5.7B; Gross margin: 74.9%; EPS: 0.62

Q2, 2025

Primary value

Revenue: $14.7B

Additional metrics

Gross profit: $10.9B; Net income: $2.9B; Operating expense: $7.8B; Gross margin: 74.2%; EPS: 0.51

Q2, 2025

Primary value

Revenue: $14.7B

Additional metrics

Gross profit: $10.9B; Net income: $2.9B; Operating expense: $5.9B; Gross margin: 74.2%; EPS: 0.51

Q1, 2025

Primary value

Revenue: $13.7B

Additional metrics

Gross profit: $10.9B; Net income: $3B; Operating expense: $8.1B; Gross margin: 79.3%; EPS: 0.52

Q1, 2025

Primary value

Revenue: $13.7B

Additional metrics

Gross profit: $10.9B; Net income: $3B; Operating expense: $5.2B; Gross margin: 79.3%; EPS: 0.52

FY, 2024

Fiscal Year

Primary value

Revenue: $63.6B

Additional metrics

Gross profit: $45.8B; Net income: $8.1B; Operating expense: $37.8B; Gross margin: 71.9%; EPS: 1.41

Q3, 2024

Primary value

Revenue: $17.7B

Additional metrics

Gross profit: $12.4B; Net income: $4.5B; Operating expense: $7.7B; Gross margin: 70.3%; EPS: 0.78

Q2, 2024

Primary value

Revenue: $13.3B

Additional metrics

Gross profit: $10B; Net income: $48M; Operating expense: $10.1B; Gross margin: 75.2%; EPS: 0.01

Q1, 2024

Primary value

Revenue: $14.9B

Additional metrics

Gross profit: $11.5B; Net income: $3.1B; Operating expense: $8.1B; Gross margin: 77.3%; EPS: 0.55

FY, 2023

Fiscal Year

Primary value

Revenue: $58.5B

Additional metrics

Gross profit: $33.5B; Net income: $2.2B; Operating expense: $32.5B; Gross margin: 57.3%; EPS: 0.37

Q3, 2023

Primary value

Revenue: $13.2B

Additional metrics

Gross profit: $4B; Net income: $-2.4B; Operating expense: $7.4B; Gross margin: 30.0%; EPS: -0.42

Period	Primary value	Additional metrics
FY, 2025 Fiscal Year	Revenue: $62.6B	Gross profit: $46.5B; Net income: $7.8B; Operating expense: $24.2B; Gross margin: 74.3%; EPS: 1.36
Q3, 2025 Q3	Revenue: $16.7B	Gross profit: $12.5B; Net income: $3.6B; Operating expense: $5.7B; Gross margin: 74.9%; EPS: 0.62
Q2, 2025 Q2	Revenue: $14.7B	Gross profit: $10.9B; Net income: $2.9B; Operating expense: $7.8B; Gross margin: 74.2%; EPS: 0.51
Q2, 2025 Q2	Revenue: $14.7B	Gross profit: $10.9B; Net income: $2.9B; Operating expense: $5.9B; Gross margin: 74.2%; EPS: 0.51
Q1, 2025 Q1	Revenue: $13.7B	Gross profit: $10.9B; Net income: $3B; Operating expense: $8.1B; Gross margin: 79.3%; EPS: 0.52
Q1, 2025 Q1	Revenue: $13.7B	Gross profit: $10.9B; Net income: $3B; Operating expense: $5.2B; Gross margin: 79.3%; EPS: 0.52
FY, 2024 Fiscal Year	Revenue: $63.6B	Gross profit: $45.8B; Net income: $8.1B; Operating expense: $37.8B; Gross margin: 71.9%; EPS: 1.41
Q3, 2024 Q3	Revenue: $17.7B	Gross profit: $12.4B; Net income: $4.5B; Operating expense: $7.7B; Gross margin: 70.3%; EPS: 0.78
Q2, 2024 Q2	Revenue: $13.3B	Gross profit: $10B; Net income: $48M; Operating expense: $10.1B; Gross margin: 75.2%; EPS: 0.01
Q1, 2024 Q1	Revenue: $14.9B	Gross profit: $11.5B; Net income: $3.1B; Operating expense: $8.1B; Gross margin: 77.3%; EPS: 0.55
FY, 2023 Fiscal Year	Revenue: $58.5B	Gross profit: $33.5B; Net income: $2.2B; Operating expense: $32.5B; Gross margin: 57.3%; EPS: 0.37
Q3, 2023 Q3	Revenue: $13.2B	Gross profit: $4B; Net income: $-2.4B; Operating expense: $7.4B; Gross margin: 30.0%; EPS: -0.42

Funding rounds

Funding history and recent round context.

Post-IPO Debt

EUR 3.3B

2025-05-01

Post-IPO Equity

$1B

2024-10-07 | Starboard Value

Post-IPO Debt

$31B

2023-05-16

Grant

$2B

2020-12-01 | HHS Administration for Strategic Preparedness and Response

Grant

$1.9B

2020-07-01

Grant

$5M

2018-05-01

Post-IPO Equity

1983-03-01

Post-IPO Debt

Acquisitions and corporate activity

Acquisitions and corporate activity captured in the source dataset.

Metsera, Inc.

$7.3B

2025-09-01 | Acquisition List Source 5

Seagen

$43B

2024-01-29 | Acquisition List Source 1

Lucira Health, Inc.

$36.4M

2023-04-01 | Acquisition List Source 5

Seagen

$43B

2023-03-13 | Acquisition List Source 2

Seagen, Inc.

$43B

2023-03-01 | Acquisition List Source 5

Global Blood Therapeutics

$5.4B

2022-10-05 | Acquisition List Source 1

GBT

$5.7B

2022-10-05 | Acquisition List Source 1

Biohaven

$11.8B

2022-10-03 | Acquisition List Source 1

ResApp Health

$179M

2022-09-27 | Acquisition List Source 1

Global Blood Therapeutics

$5.4B

2022-08-08 | Acquisition List Source 2

Global Blood Therapeutics, Inc.

$5.4B

2022-08-01 | Acquisition List Source 5

ReViral

$525M

2022-06-09 | Acquisition List Source 1

Biohaven Pharmaceutical

$11.6B

2022-05-10 | Acquisition List Source 2

Biohaven Pharmaceutical Holding Company Ltd.

$11.6B

2022-05-01 | Acquisition List Source 5

ResApp Health

$133.4M

2022-04-12 | Acquisition List Source 2

ReViral

$525M

2022-04-07 | Acquisition List Source 2

ReViral Ltd.

$525M

2022-04-01 | Acquisition List Source 5

Arena

$6.7B

2022-03-11 | Acquisition List Source 1

Arena Pharmaceuticals

$6.7B

2021-12-13 | Acquisition List Source 2

Trillium Therapeutics

$2.3B

2021-11-17 | Acquisition List Source 1

Trillium Therapeutics

$2.3B

2021-08-23 | Acquisition List Source 2

Amplyx Pharmaceuticals

Acquisition

2021-04-28 | Acquisition List Source 1

Arixa Pharmaceuticals

Acquisition

2020-10-22 | Acquisition List Source 2

Array BioPharma

$11.4B

2019-07-30 | Acquisition List Source 1

Array BioPharma

$11.4B

2019-06-17 | Acquisition List Source 2

Therachon

$340M

2019-05-08 | Acquisition List Source 1

Medivation

$14B

2016-08-22 | Acquisition List Source 1

Bamboo Therapeutics

$654M

2016-08-01 | Acquisition List Source 1

BIND Therapeutics, Inc.

$40M

2016-07-27 | Acquisition List Source 1

Anacor Pharmaceuticals

$5.2B

2016-06-24 | Acquisition List Source 1

Hospira

$15B

2015-02-05 | Acquisition List Source 1

Redvax

Acquisition

2015-01-05 | Acquisition List Source 1

Baxter International - Marketed Vaccines

$635M

2014-07-30 | Acquisition List Source 1

InnoPharma

$225M

2014-07-16 | Acquisition List Source 1

NextWave Pharmaceuticals

Acquisition

2012-10-22 | Acquisition List Source 1

Excaliard Pharmaceuticals

Acquisition

2011-11-22 | Acquisition List Source 1

ICAgen

$56M

2011-10-28 | Acquisition List Source 1

King Pharmaceuticals

Acquisition

2010-10-12 | Acquisition List Source 1

Foldrx Pharmaceuticals

Acquisition

2010-09-01 | Acquisition List Source 1

Wyeth Biopharma

Acquisition

2009-10-01 | Acquisition List Source 1

Catapult Genetics

Acquisition

2008-03-31 | Acquisition List Source 1

Serenex

Acquisition

2008-03-03 | Acquisition List Source 1

Encysive Pharmaceuticals

$195M

2008-02-20 | Acquisition List Source 1

Covx

Acquisition

2007-12-18 | Acquisition List Source 1

Coley Pharmaceutical Group

$164M

2007-11-16 | Acquisition List Source 1

BioRexis

Acquisition

2007-02-01 | Acquisition List Source 1

PowderMed

Acquisition

2006-10-09 | Acquisition List Source 1

Rinat Neuroscience

Acquisition

2006-04-07 | Acquisition List Source 1

Bioren

Acquisition

2005-08-15 | Acquisition List Source 1

Idun Pharmaceuticals

Acquisition

2005-02-24 | Acquisition List Source 1

Angiosyn

Acquisition

2005-01-21 | Acquisition List Source 1

Esperion Therapeutics

$1.3B

2003-12-21 | Acquisition List Source 1

Pharmacia

Acquisition

2002-07-15 | Acquisition List Source 1

Warner Lambert

$90B

2000-02-07 | Acquisition List Source 1

Pfizer Ireland Ventures Unlimited Company

Acquisition

Acquisition List Source 1

Pfizer Middle East and North Africa Regional Headquarter Company

Acquisition

Acquisition List Source 1

Pfizer Healthcare Ireland Unlimited Company

Acquisition

Acquisition List Source 1

Wyeth LLC

Acquisition

Acquisition List Source 1

Pfizer Specialties Limited

Acquisition

Acquisition List Source 1

Pfizer Polska Sp. z.o.o.

Acquisition

Acquisition List Source 1

GenTrac, Inc.

Acquisition

Acquisition List Source 1

Pfizer Pharmaceuticals Israel Ltd.

Acquisition

Acquisition List Source 1

G. D. Searle International Capital LLC

Acquisition

Acquisition List Source 1

Pfizer Manufacturing Austria G.m.b.H.

Acquisition

Acquisition List Source 1

Pfizer Shareholdings Intermediate SARL

Acquisition

Acquisition List Source 1

Fort Dodge Manufatura Ltda.

Acquisition

Acquisition List Source 1

Pfizer Canada ULC / Pfizer Canada SRI

Acquisition

Acquisition List Source 1

Biohaven Pharmaceutical Holding Company Limited

Acquisition

Acquisition List Source 1

Agouron Pharmaceuticals, LLC

Acquisition

Acquisition List Source 1

Pfizer Pharmaceuticals Global B.V.

Acquisition

Acquisition List Source 1

Pfizer Colombia Spinco I LLC

Acquisition

Acquisition List Source 1

Pfizer (China) Research and Development Co. Ltd.

Acquisition

Acquisition List Source 1

Pfizer Investment Enterprises Holdings Pte. Ltd.

Acquisition

Acquisition List Source 1

Pfizer Laboratories Limited

Acquisition

Acquisition List Source 1

Pfizer PFE Service Company Holding B.V.

Acquisition

Acquisition List Source 1

Pfizer (Wuhan) Research and Development Co. Ltd.

Acquisition

Acquisition List Source 1

Hospira, Inc.

Acquisition

Acquisition List Source 1

Pfizer Pakistan Limited

Acquisition

Acquisition List Source 1

Array BioPharma Inc.

Acquisition

Acquisition List Source 1

Pfizer Investments Corporation

Acquisition

Acquisition List Source 1

PF Argentum US Corporation

Acquisition

Acquisition List Source 1

Warner Lambert del Uruguay S.A.

Acquisition

Acquisition List Source 1

Cyanamid de Argentina, S.A.

Acquisition

Acquisition List Source 1

Pfizer Health AB

Acquisition

Acquisition List Source 1

Vicuron Holdings LLC

Acquisition

Acquisition List Source 1

Pfizer Worldwide Services Unlimited Company

Acquisition

Acquisition List Source 1

Pfizer Research (NC), Inc.

Acquisition

Acquisition List Source 1

Pfizer Corporation Austria Gesellschaft m.b.H.

Acquisition

Acquisition List Source 1

P-D Co., LLC

Acquisition

Acquisition List Source 1

Sinergis Farma-Produtos Farmaceuticos, Lda.

Acquisition

Acquisition List Source 1

Wyeth Holdings LLC

Acquisition

Acquisition List Source 1

Parkedale Pharmaceuticals, Inc.

Acquisition

Acquisition List Source 1

AHP Manufacturing B.V.

Acquisition

Acquisition List Source 1

Pfizer Croatia d.o.o.

Acquisition

Acquisition List Source 1

Pfizer Venezuela, S.A.

Acquisition

Acquisition List Source 1

Wyeth Subsidiary Illinois Corporation

Acquisition

Acquisition List Source 1

Pfizer Pharma GmbH

Acquisition

Acquisition List Source 1

Pfizer (North Carolina) LLC

Acquisition

Acquisition List Source 1

Solinor LLC

Acquisition

Acquisition List Source 1

PF OFG South Korea 1 B.V.

Acquisition

Acquisition List Source 1

Pfizer Medicamentos Genericos e Participacoes Ltda.

Acquisition

Acquisition List Source 1

Medivation Services LLC

Acquisition

Acquisition List Source 1

Pharmacia Inter-American LLC

Acquisition

Acquisition List Source 1

Pfizer Australia Holdings Pty Limited

Acquisition

Acquisition List Source 1

Hospira UK Limited

Acquisition

Acquisition List Source 1

Pfizer Limited (India)

Acquisition

Acquisition List Source 1

Pfizer Biopharma Egypt LLC

Acquisition

Acquisition List Source 1

Pfizer Laboratories (Pty) Limited

Acquisition

Acquisition List Source 1

Pfizer Pharmaceuticals Tunisie Sarl

Acquisition

Acquisition List Source 1

Pfizer Ireland PFE Holding 2 LLC

Acquisition

Acquisition List Source 1

Sugen LLC

Acquisition

Acquisition List Source 1

Pfizer New Zealand Limited

Acquisition

Acquisition List Source 1

Pfizer PFE Eastern Investments B.V.

Acquisition

Acquisition List Source 1

Pfizer Intermediate Holdings 1 Pte. Ltd.

Acquisition

Acquisition List Source 1

Pfizer Oy

Acquisition

Acquisition List Source 1

Metsera

Acquisition

Acquisition List Source 2

Audience analytics

Web visibility, demand, and topics

Use these signals to understand discoverability, demand quality, search interest, and audience fit.

Monthly visits

1.9M

Latest monthly visits value available from the source dataset.

Global web rank

#32,098

Lower rank values indicate stronger web visibility in the source dataset.

Bounce rate

52.0%

Latest bounce rate value available from the source dataset.

Pages per visit

2.33

Latest pages per visit value available from the source dataset.

Average visit duration

2m 39s

Latest average visit duration value available from the source dataset.

Estimated monthly page views

4.5M

Derived estimate calculated as monthly visits multiplied by pages per visit.

Website visits

Website visits trend from the latest source snapshots.

LinkedIn followers

LinkedIn followers trend from the latest source snapshots.

Website visits by country

United States47.63

India8.80

Germany3.8

Canada3.4

Japan3.3

Employees, hiring, attrition, and compensation

This section groups org scale, hiring motion, employee movement, department mix, and salary benchmarks so teams can qualify operating momentum and budget signals.

Employees

103.3K

Latest employees value available from the source dataset.

Inferred employees

59.6K

Latest inferred employees value available from the source dataset.

Open roles

709

Latest open roles value available from the source dataset.

Departures

Latest departures value available from the source dataset.

Employee attrition rate

0.0%

Latest employee attrition rate value available from the source dataset.

Hiring intensity

6.9 roles / 1K employees

Derived signal showing open roles normalized by employee count.

Employee headcount

Employee headcount trend from the latest source snapshots.

Inferred employees

Inferred employees trend from the latest source snapshots.

Open job postings

Open job postings trend from the latest source snapshots.

Employee attrition rate

Employee attrition rate trend from the latest source snapshots.

Employee count by department

Other Department8.6K

Operations8.5K

Medical8.1K

Research7.9K

Technical5.8K

Sales5.4K

General Management3K

Employee count by seniority

Specialist22.6K

Manager12.2K

Other Management10.2K

Senior9.3K

Director4.8K

Head2.1K

Intern783

Employee count by region

Northern America25.6K

Northern Europe6K

Western Europe5.3K

Southern Asia4.7K

Latin America4.5K

Southern Europe4.1K

Eastern Asia2.5K

Top employee countries

United States24.7K

India4.2K

Ireland3.6K

Belgium2.6K

United Kingdom1.9K

China1.7K

Italy1.6K

Active job openings

Selected open roles that reveal current hiring demand.

ISF Specialist Internal Medicine - Toscana

Open role

3144752909

ISF Specialist Internal Medicine - Veneto

Open role

3144758282

炎症免疫-医学信息沟通地区经理-广州（皮科产品）

Open role

3989466862

Pflichtpraktikant (m/w/d) im Bereich Finance

Open role

4092406488

Pharmazeut (m/w/d) im Praktikum

Open role

4093803312

（高级）医学信息沟通专员

Open role

4094654809

Metabolism BU Sales Lead

Open role

4098515823

TA & Skills Training Manager

Open role

4202525582

Showing 8 of 18 available records.

Where employees came from

Common previous employers visible in employee profile movement.

GSK

3.6K employee movements

Internal profile link

Novartis

2.7K employee movements

Internal profile link

Sanofi

2.6K employee movements

Internal profile link

Hospira

2.4K employee movements

Internal profile link

Seagen

2.1K employee movements

Internal profile link

AstraZeneca

1.9K employee movements

Internal profile link

Bristol Myers Squibb

1.8K employee movements

Internal profile link

Abbott

1.5K employee movements

Internal profile link

Showing 8 of 9 available records.

Where employees go next

Common next employers visible in employee profile movement.

GSK

4.4K employee movements

Internal profile link

Novartis

4.2K employee movements

Internal profile link

Sanofi

3.6K employee movements

Internal profile link

Johnson & Johnson

3.1K employee movements

Internal profile link

AstraZeneca

3.1K employee movements

Internal profile link

Bristol Myers Squibb

2.5K employee movements

Internal profile link

Zoetis

2.5K employee movements

Internal profile link

Viatris

2.4K employee movements

Internal profile link

Showing 8 of 9 available records.

Product and reputation

Product readiness, customer proof, and employee sentiment

Product availability, public reviews, and employee sentiment help visitors understand whether the company is mature, documented, reviewable, and operationally healthy.

Product availability Q&A

Buyer-facing product availability signals in question-and-answer format.

Is pricing information available?

Yes. The source snapshot lists pricing information for this company.

Source availability signal

Is a free trial listed?

No. The source snapshot does not list a free trial for this company.

Source availability signal

Can buyers request a demo?

No. The source snapshot does not list a demo motion for this company.

Source availability signal

Is the product downloadable?

Yes. The source snapshot lists downloadable software for this company.

Source availability signal

Are mobile apps listed?

No. The source snapshot does not list mobile apps for this company.

Source availability signal

Is public documentation listed?

No. The source snapshot does not list public documentation for this company.

Source availability signal

Are online reviews listed?

No. The source snapshot does not list online reviews for this company.

Source availability signal

Company graph

Technology, leadership, competitors, funding, and corporate activity

These data points help sales, partnerships, analysts, and researchers understand how the company operates, who surrounds it, and where it may be moving next.

Verified technologies

Detected tools and systems verified in the source dataset.

Sqlite

Verified technology

Last verified 2026-05-04 | First seen 2025-04-08

Python

Verified technology

Last verified 2026-05-04 | First seen 2024-04-04

Ecl

Verified technology

Last verified 2026-05-04 | First seen 2025-08-17

Azure Data Lake

Verified technology

Last verified 2026-05-04 | First seen 2024-07-09

Postman

Verified technology

Last verified 2026-05-04 | First seen 2024-05-20

Unix Shell Scripts

Verified technology

Last verified 2026-05-04 | First seen 2025-08-17

Sap Crystal Reports

Verified technology

Last verified 2026-05-04 | First seen 2026-01-25

Openai

Verified technology

Last verified 2026-05-04 | First seen 2024-05-20

Showing 8 of 24 available records.

Market alternatives and competitors

Comparable companies surfaced by the source dataset.

Astellas Pharma

Comparable company

Market alternative

Lilly

Comparable company

Market alternative

Bayer

Comparable company

Market alternative

Novartis

Comparable company

Market alternative

Merck Group

Comparable company

Market alternative

Gsk

Comparable company

Market alternative

Amgen

Comparable company

Market alternative

Boehringer Ingelheim

Comparable company

Market alternative

Showing 8 of 12 available records.

Leadership and senior operators

Senior employees and operators visible in the source dataset.

CQA Terri Puglise

Associate Director Compliance

CQA Terri Puglise

Associate Director

Michael Cuddy

Transfer Pricing Operations Lead

Rebecca Lacey

Regional Legal Lead, APAC

Jeremy Cress

Data Governance And Operations Head

Krzysztof Krzosek

Director Auditor

Irina Pollmeier

Business Operations Lead, People Experience International Developed Markets

Maria-Gabriella Di Matteo

Director CTRO Team Manager

Showing 8 of 12 available records.

Recent executive arrivals

Recent leadership and senior employee arrival signals.

Andrea Cruz Garcia

Business Unit Director OncoHematology North LATAM - NoLa

Dec 2025

Santiago Medina Dupont

North LATAM Brand Lead Vaccines Portfolio

Dec 2025

Mina Tchilianska

COUNTRY PORTFOLIO LEAD INTERNAL MEDDICINE&RRARE DISEASES

Dec 2025

Livia Hofer

Country Portfolio Lead - Hematology & Breast

Dec 2025

Raphaela Böhm

Country Portfolio Lead Vaccines

Dec 2025

Andreas Lindström

Country Portfolio Lead

Dec 2025

Andrea Sibylla Dür

Cluster Commercial Lead Rare Disease

Dec 2025

Edward Cox

Head of Digital Health & Medicines (DHM) and Head of R&D+BI Forward Impact Teams (R&D+BI FIT)

Jan 2026

Recent executive departures

Recent leadership and senior employee departure signals.

Alan Lambe

Director, Platform Product Architecture

Feb 2026

Hae-Yeon Yoon

Legal Affairs Director

Dec 2025

Kaliopi Velasco

Health Solution Partner NIP Vaccines

Dec 2025

Maria Magdalena Meisel

Brand Lead Internal Medicine

Dec 2025

Nervin Lawendy

Senior Director, Clinical Program Lead, Gastroenterology Portfolio, Inflammation & Immunology

Dec 2025

Stratos Christeas

Health Solution Partner Oncology

Dec 2025

Kelsey Britton

Head of Cyber Defense

Jan 2026

Renée Molenaar-Overmeer

Medical Affairs Lead Oncology

Feb 2026

Company locations

Known company locations and office addresses.

Primary location

New York; New York, New York 10017, US

Office location

31 Tuas South Ave 6; Singapore, Singapore 637578, SG

Office location

500 Arcola Rd; Collegeville, PA 19426, US

Office location

1040 Swabia Ct; Durham, NC 27703, US

Office location

Via Isonzo, 71; Latina, Laz. 04100, IT

Office location

No. 177, Sec 2, Zhong Zheng E. Rd.; New Taipei City, New Taipei City 251, TW

Office location

85 Bute Ln; Sandton, Gauteng 2196, ZA

Office location

1200 Parkdale Rd; Rochester, MI 48307, US

Recent company updates

Recent company update signals from the source dataset.

Scott and Natalie, medicinal chemists at Pfizer, and their lab work to create and isolate compounds to be tes…

1.5K reactions; 38 comments

2026-03-26 | Scott and Natalie, medicinal chemists at Pfizer, and their lab work to create and isolate compounds to be tested as potential drug candidates. During this process, compounds must be closely monitored and extensively tes…

As colorectal cancer rates rise in young adults, advances in science are offering new hope for patients. Th…

737 reactions; 25 comments

2026-03-26 | As colorectal cancer rates rise in young adults, advances in science are offering new hope for patients. This story explores how updated screening guidelines, advances in precision medicine, along with strides in rese…

Scott and Natalie, medicinal chemists at Pfizer, and their lab work to create and isolate compounds to be tes…

1.3K reactions; 28 comments

As colorectal cancer rates rise in young adults, advances in science are offering new hope for patients. Th…

712 reactions; 20 comments

Pfizer is proud to champion this initiative led by Amyloidosis Research Consortium. Pre-competitive initiativ…

255 reactions; 11 comments

2026-03-13 | Pfizer is proud to champion this initiative led by Amyloidosis Research Consortium. Pre-competitive initiatives like ASPIRE allow organizations to pool expertise, accelerate research, and address challenges that are too…

Pfizer is proud to champion this initiative led by Amyloidosis Research Consortium. Pre-competitive initiativ…

243 reactions; 10 comments

Industry classification codes

SIC, NAICS, industry, and keyword classification signals.

Industry

Pharmaceutical Manufacturing

industry

Categories and keywords

Categories And Keywords

Public market signal

Pfizer stock snapshot

TradingView market widget for NYSE:PFE.

NYSE:PFE

Pfizer FAQs

Company profile

Want verified contact data for Pfizer?

Datakart.ai gives you verified email addresses, direct dials, and buying intent signals for key decision-makers at Pfizer and 1,700+ other companies.

Start your free trial Directory